HOME >> BIOLOGY >> NEWS
JCI Table of Contents, September 15, 2003

A cheap and easy way to treat Parkinson disease

A team of researchers, led by Serge Przedborski, at Columbia University in New York, have demonstrated that infusion of D-beta-hydroxybutyrate (D-beta-HB) to mice suffering from Parkinson disease restored impaired brain function and protected against neurodegeneration and motor skill abnormalities. D-beta-HB, already utilized in the treatment of epilepsy, may represent a cheap and easy way to treat Parkinson disease.

Parkinson disease is the second most common neurodegenerative disorder after Alzheimer disease. Sufferers experience motor skill abnormalities including tremor, muscle stiffness, and unstable voluntary movements and posture. The main pathological feature of the Parkinson brain is the loss of dopaminergic neurons.

Reported in an article in the September 15 issue of the Journal of Clinical Investigation, Przedborski and colleagues administered the neurotoxin MPTP to mice, which caused dopaminergic neurodegeneration and deficits in the mitochondrial electron transport chain reminiscent of Parkinson disease. Using this model of disease, the authors showed that the infusion of the ketone body D-beta-HB restored mitochondrial respiration and protected against MPTP-induced neurodegeneration and motor deficits. The study supports a critical role for mitochondrial defect in Parkinson disease.

Ketone bodies are already successfully used in the treatment of epilepsy. They are also able to penetrate the blood-brain barrier that often prevents potentially beneficial drugs from entering the brain.

D-beta-HB may therefore be considered as a novel form of neuroprotective therapy in the treatment of Parksinson disease.

TITLE: D-beta-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

AUTHOR CONTACT:
Serge Przedborski
Columbia University, New York, New York, USA.
Phone: (212) 305-1540
Fax: (212)
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
15-Sep-2003


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology news :

1. JCI Table of Contents, 15 July 2004
2. JCI Table of Contents, January 15 2004
3. JCI Table of Contents, November 3, 2003
4. JCI Table of Contents, 1 October, 2003
5. JCI Table of Contents
6. JCI Table of Contents, 15 August 2003
7. JCI Table of Contents, May 1, 2003
8. JCI Table of Contents, April 1, 2003
9. JCI Table of Contents, March 14, 2003
10. JCI Table of Contents, January 2, 2003
11. JCI Table of Contents, December 2, 2002

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/14/2018)... ... December 14, 2018 , ... uBiome, ... “Method and System for Microbiome-Derived Diagnostics and Therapeutics” by the US Patent and ... 2014. The patent is an invention by uBiome collaborators Dr. Zachary Apte, Dr. ...
(Date:12/13/2018)... Fla. (PRWEB) , ... December 12, 2018 , ... New ... preventing the growing problem of drowsy and distracted driving, one of the main causes ... under the guidance of Dr. Kanwal Gagneja , assistant professor of computer science, ...
(Date:12/5/2018)... ... December 05, 2018 , ... Surgical Theater brings ... TN, from December 6-9, 2018 at booth #312. AANS/CNS provides Pediatric Neurosurgeons an ... the treatment continuum – from the consultation, to surgical planning, and into the ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... ... Rascal was adopted from a local shelter when he was around two years old. ... six weeks after he was adopted, he tore his right cruciate ligament. Though he ... after such a traumatic injury. , Sure enough, when Rascal was about nine years old, ...
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos ... its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is an orally active ... took place in South Korea. , This Phase 1 randomized, double-blind, placebo-controlled ...
(Date:12/20/2018)... (PRWEB) , ... December 20, 2018 , ... New Year’s ... with major changes in regulations in the European Union (EU) on the horizon, Jim ... to consider. , “The transition to the EU Medical Device Regulation (MDR), digital health, ...
(Date:12/18/2018)... (PRWEB) , ... December 18, 2018 , ... Patients with ... lumpectomy have better quality of life post-treatment versus whole breast irradiation, a new study ... are typically treated with whole breast irradiation after removal of the cancerous tumor because ...
Breaking Biology Technology:
Cached News: